October 21, 2015

Biotech: My love-hate relationship

My love

RDUSa

My hate

CELGa

The two charts above are from recent trades I have taken. Charts created in AmiBroker.

On July 20, 2015 IBB, iShares Nasdaq Biotechnology ETF, made a closing high of 398.  About three months later it closed at 289 for 27% loss. A very common thing I hear from traders is that they “don’t trade biotechnology or pharmaceutical stocks.” I completely understand. These stocks tend to be very volatile and news driven. But does removing these stocks really reduce your drawdowns? What happens to your Compounded Growth Rate? Time to see what the research shows us.

Continue reading

September 2, 2015

What I am reading: Sept. 2, 2015

Recent articles that I found interesting and made me think. For more articles see the quant mashup Quantocracy.

Was Monday’s ETF Collapse Just A Warmup?

“The ETF can’t be more liquid than the underlying, and we know the underlying can become highly illiquid.”

 

Computers are the new Dumb Money

“Rational, experienced people understood that an ETF with holdings that were down an average of 5% should not have a share price down 30%.”

 

Avoiding the Big Drawdown: Is Downside Protection Helpful or Heresy?

‘Chasing the Investing Unicorn: Give me “High Returns with Limited Risk”’

 

Algorithm Aversion — Why people don’t follow the model!

“However, given this knowledge that models beat experts, forecasters still prefer to use the human (expert) prediction as opposed to using the model.”

Good Quant Trading,

The Health of Stock Mean Reversion: Dead, Dying or Doing Just Fine

My second post on this blog was a look at mean reversion, Is mean reversion dead? Given I am using a new data provider(Norgate Data), it has been almost two years since that post and there have been other articles on this recently, I figured it was time to check again. The research will focus on Russell 1000 stocks since 1995. The test is back to 1995 covers 3 bull markets and 2 bear markets.

Continue reading

July 22, 2015

Multiple Time Frames for Scoring ETF Rotational Strategies

Today we have a guest post from David Weilmuenster who I worked with while at Connors Research.

A widely applied technique for scoring assets in rotational systems is to rank those assets by their price momentum, or return, over a given historical window and to rotate into the assets with higher momentum. This approach seeks to capitalize on the well-demonstrated tendency for price momentum to persist. But, it begs some questions:

  1. “What is an appropriate historical period for measuring price momentum?” Clearly, the momentum of a given asset can rank quite differently compared to the tradable universe over 1 month, 3 months, or 6 months.
  2. “Is one historical period sufficient?” If relative momentum can vary widely depending on the historical window, would it be better to consider multiple slices of history?
  3. Is higher momentum always preferable to lower momentum, especially if the system rules filter the tradable universe before scoring the ETFs for rotation?

Continue reading

1 11 12 13 14 15 19